Trials / Terminated
TerminatedNCT00206063
Long Term Open Follow-up With H376/95 vs. Warfarin
Long-Term Treatment With the Oral Direct Thrombin Inhibitor Ximelagatran, Compared to Warfarin, as Stroke Prophylaxis in Patients With Atrial Fibrillation. A Long Term Follow-Up Study
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 220 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EXANTA |
Timeline
- Start date
- 1999-08-01
- Primary completion
- 2004-06-01
- Completion
- 2006-04-01
- First posted
- 2005-09-21
- Last updated
- 2010-11-15
Locations
19 sites across 9 countries: United States, Belgium, Czechia, Denmark, Finland, Norway, Poland, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00206063. Inclusion in this directory is not an endorsement.